Celltrion Covid
Scope
Date
~
-
Travel & Leisure
Korean convention sector enjoys increase in events post-pandemic
Coex Convention & Exhibition Center, the largest event complex in Seoul, was crowded on Friday for a smart factory and plant automation fair.&ld...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Economy
S.Korea's Engel coefficient rises sharply amid COVID-19 pandemic
South Korea’s low-income households are feeling the pinch of rising food prices amid the COVID-19 pandemic, according to a report by a local t...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Feb 16, 2023 (Gmt+09:00)
-
Companies
China's alleged Korean trademark piracy surges during COVID-19
South Korean companies have witnessed a sharp increase in alleged trademark piracy in China over the past few years, as COVID-19 curbed their overse...
Feb 07, 2023 (Gmt+09:00)
-
Retail
Galleria Dept. Store's sales from foreigners increase 500% for past 6 months
South Korea's department store group Galleria Department Store said on Tuesday that for the past six months (between August last year and January th...
Feb 07, 2023 (Gmt+09:00)
-
Airlines
Jeju Air to resume flights on Incheon-Shizuoka route in March
Jeju Air Co., a South Korean budget airline, said on Thursday that it would resume its flights connecting Incheon with two small cities in Japan, Ma...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion increases its stake in British ADC developer Iksuda
Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare lands biosimilar deal in Brazil for 2nd straight year
South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Real estate
Hotels in top Seoul tourist area on sale due to rate hikes
South Korea's KB Asset Management Co. is set to sell two three-star hotel buildings in Myeong-dong, one of the most popular spots for foreign touris...
Jan 04, 2023 (Gmt+09:00)
-
Airlines
Korean LCCs cancel China-bound flights due to COVID-19
Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Travel & Leisure
Korea's int'l passenger traffic exceeds domestic for 1st time since pandemic
The volume of international passengers in South Korea has exceeded that of domestic flights for the first time since the outbreak of the COVID-19 pa...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Airlines
Korea-China air flights set to rise with Beijing’s eased zero-COVID policy
Air flights between South Korea and China are set to rise significantly next year with the Chinese government issuing new guidelines easing its stri...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Perspectives
China’s COVID reopening poses risks and opportunities
News that Beijing is finally scrapping its growth-killing “zero COVID” policy seems the equivalent of answered prayers for Asia. And it co...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's 2021 bio sector output $15.4 bn; 5-year annual growth 20%
South Korea's bio industry last year exceeded 20 trillion won ($15.4 billion) in production for the first time and continues to see strong growth.Th...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
PCL’s diagnostic kit measures concentration of COVID-19 antibodies
PCL Inc., a South Korean in vitro diagnostics device maker, plans to bring two test kits – one that simultaneously detects COVID-19 and influenza infe...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to seek FDA approval for sale of Remsima SC by year-end
Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...
Nov 28, 2022 (Gmt+09:00)
-
Travel & Leisure
MZers drive Korea's indoor golf facility pandemic boom
Indoor golf facilities’ revenue in South Korea has skyrocketed amid the pandemic, thanks to millennials and Generation Zers' soaring consumpti...
Nov 21, 2022 (Gmt+09:00)